Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
about
Neutrophil responses to injury or inflammation impair peripheral gustatory functionEffects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia.Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4-5: a retrospective single center study.Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismSerum fibroblast growth factor-23 is associated with incident kidney disease.Nuclear receptors in renal diseaseEffects of calcitriol on the immune system: new possibilities in the treatment of glomerulonephritis.Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.Vitamin D therapy in chronic kidney disease and end stage renal disease.Effects of vitamin D on kidney histology and trpv1 channels in doxorubicin-induced nephropathyRole of Paricalcitol in Modulating the Immune Response in Patients with Renal DiseaseAssociation of Retinoid X Receptor Alpha Gene Polymorphism with Clinical Course of Chronic Glomerulonephritis.Nuclear hormone receptors in podocytesLessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic NephropathyVitamin D status and outcomes after renal transplantation.Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signalingMineral metabolism disturbances in patients with chronic kidney disease.Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosisRole of vitamin D in chronic kidney disease.Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.25-hydroxyvitamin D levels, race, and the progression of kidney disease.A new role for vitamin D receptor activation in chronic kidney disease.Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D.Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.Calcitriol ameliorates renal damage in a pre-established proteinuria model.1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.Effects of vitamin D3 (cholecalciferol) on adriamycin-induced nephrotoxicity.Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.Effects of vitamins E, A and D on MDA, GSH, NO levels and SOD activities in 5/6 nephrectomized rats.Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.1,25-Dihydroxyvitamin D3 inhibits the proliferation of rat mesangial cells induced by high glucose via DDIT4.Histoprotective effect of vitamin D against carbon tetrachloride nephrotoxicity in rats.Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
P2860
Q33787918-0EF643C1-3D77-49B5-9626-F9D431D5B98BQ34155747-60B817E9-39A3-44BA-871D-146B8F65907FQ34408823-D1891392-E239-4DC6-882C-F9A3FE4F4D80Q34475608-F44CD9AC-F196-4BFC-B01A-7130574E4139Q34719267-A405AC68-570A-4B2E-91C3-D32E2D5B9367Q34787817-F15E40C7-7B4B-489E-9162-9EBB4C7BE608Q35120702-3731B665-DCF6-44E9-895A-0E00FCF65C05Q35608853-1814B026-A4F2-4A67-A805-E4A815362FD2Q35667633-148570F7-BBBD-4743-9213-67C45D6DAD1CQ35758581-4F3BF54B-BE1E-4564-A428-397AF278D172Q35835824-BD944AAA-28D0-4532-9B92-9C7842DBF737Q36103344-C69608A1-3390-4431-8F13-D1B20762400EQ36368217-C98BD81D-7D55-4E8C-9664-7E709B0BBBB1Q36527306-C74AFE17-2F9F-4733-AAC8-96B17D81293EQ36734406-081AB8DA-D8DB-4EA5-A793-15E76A3FD3D4Q36796584-76326905-734C-49A1-8821-5B6421BB1B58Q36842418-CC982785-E78D-4E66-A1DC-10B021879781Q36884206-1C7529E7-B276-48B5-A05A-5A705FFB592FQ37141825-A91BEF87-9DE4-4765-9AB0-DF9ABAACCD50Q37226885-4B329EC8-D1FB-4211-8E3D-52B8D68E9F84Q37376932-C5F659AD-DA8E-488E-88A2-B5C99F7EAA02Q37477768-448CA019-6028-42C6-A16C-47D05CAFF7AEQ37558961-C40FE6E1-9F97-4424-8F8C-8B601D355836Q37842680-E2DB040B-D6EA-4052-B985-80E0E7766610Q39770504-0282B8B4-FF29-40BA-A617-F4A0370DF8D1Q40845859-B60CA3F7-9818-4D1B-8CC1-476644ED82E9Q40891356-787E88D5-8D06-47D0-8C8D-890BD0DC1DA3Q41897679-9A58DC67-EFFD-4D3C-AA82-BF36C119E9B7Q43259006-00903C38-C992-4054-84B7-125E6CC9C08DQ45993878-2A3AAA49-BCFE-4F79-BBF7-D90A91A5D952Q46083196-B30AA99F-85B0-4861-8C62-A529402B10C4Q46666162-9EE553CA-40B4-4323-8CF0-24A75FE9471BQ46875997-856976E1-44A0-4825-B8A6-1E419D1E5BF6Q49281806-A35A28EF-D96B-4479-8D31-5532FA1C953FQ52923000-009BFC91-471A-47E3-ADC5-400141C52CF8Q53197248-057C1FA9-8C29-4F3C-832F-89DD7EA82860Q54642763-31B25DCA-EC27-494D-B46D-EA2B9247ED7FQ59034810-CF21FC71-9784-4251-9D5D-23FA56E8C491
P2860
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@en
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@nl
type
label
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@en
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@nl
prefLabel
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@en
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
@nl
P2093
P50
P1433
P1476
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
@en
P2093
P356
10.1046/J.1523-1755.2001.00775.X
P407
P577
2001-07-01T00:00:00Z
P5875
P6179
1025638249